Palisade Bio, Inc. · NASDAQ:PALI
Soleus Capital Master Fund, L.P. reported a 5.40% stake in Palisade Bio, Inc. (Schedule 13G)
Event May 26, 2026 · Filed May 27, 2026
Soleus Capital Master Fund, L.P. reported a 5.40% stake in Palisade Bio, Inc., 9,353,687 shares, as a passive investor on May 26, 2026. Filed May 27, 2026 (Schedule 13G).
- Stake
- 5.40%
- Shares
- 9,353,687
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Soleus Capital Master Fund, L.P. | 5.40% | 9,353,687 |
| Soleus Capital, LLC | 5.40% | 9,353,687 |
| Soleus Capital Group, LLC | 5.40% | 9,353,687 |
| Soleus Capital Management, L.P. | 5.40% | 9,353,687 |
| Soleus GP, LLC | 5.40% | 9,353,687 |
| Guy Levy | 5.40% | 9,353,687 |
Source
Related
- Palisade Bio, Inc.
- Soleus Capital Master Fund, L.P.
- Palisade Bio, Inc. shareholders
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · Aug 13, 2026
- Form 4 · Capers Julien E. · Oct 21, 2026
- Form 4 · Finley John David · Oct 7, 2026
- Form 4 · Jones Mitchell Lawrence · Oct 7, 2026
- Form 4 · Williams Donald Allen · Oct 5, 2026
- Form 4 · Finley John David · Aug 21, 2026